Top Markets
#1 Derive Derive +34.71%
#2 Cross Cross +19.02%
#3 Geodnet Geodnet +11.72%
#4 Palladium Network Palladium Network +11.56%
#5 Gama Token Gama Token +9.18%
#6 Quantum Resistant Ledger Quantum Resistant Ledger +7.74%
#7 Steakhouse ETH Morpho Vault Steakhouse ETH Morpho Vault +7.02%
#8 The Bitcoin Bull The Bitcoin Bull +6.75%
#9 Based Based +6.44%
#10 Cap Cap +5.83%
Coin of the day
Derive Derive
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Perpetua Medical AB (publ) Perpetua Medical AB (publ)

Perpetua Medical AB (publ)

PERP-B
Rang in Aktien #35990
Perpetua Medical AB (publ) delivers a range of solutions and products in Sweden... Perpetua Medical AB (publ) delivers a range of solutions and products in Sweden specifically tailored for the application and management of injectable medications. Among its principal offerings is DrugLog, a system designed to mitigate errors in pharmacy medication dispensing. Another key product, WasteLog, serves as a device for analyzing and reconciling discarded and returned controlled injectable substances. Additionally, PrepLog, built upon the core technology of DrugLog, integrates with existing prescription or medication management systems to enable the verification of drug preparations. The company, which was established in 2007 and maintains its headquarters in Uppsala, Sweden, officially changed its name to Perpetua Medical AB (publ) in April 2024, having formerly been known as Pharmacolog i Uppsala AB (publ). Perpetua Medical AB (publ) operates as a subsidiary entity of Nolsterby Invest AB.
Aktienkurs
$0.37305641
Zuletzt synchronisiert: 2026-08-14
Marktkapitalisierung
$3.19M
Veränderung (1 Tag)
-2.62%
Veränderung (1 Jahr)
-22.98%
Land
SE
Handel Perpetua Medical AB (publ) (PERP-B)

Kategorie

Healthcare
P/S-Verhältnis für Perpetua Medical AB (publ) (PERP-B)
P/S-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Perpetua Medical AB (publ) beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/S-Verhältnis bei 0.
P/S-Verlauf für Perpetua Medical AB (publ) von 2026 bis 2026
P/S-Verhältnis zum Jahresende
Jahr P/S-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/S-Verhältnis P/S-Verhältnis-Differenz Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
4.13 -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
5.03 -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
2.78 -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
3.67 -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
8.10 -
US